Lamers and colleagues presented evidence that patients with specific atypical features show associations with immuno-metabolic outcomes including IL-6, CRP and metabolic syndrome components, both cross-sectionally and longitudinally (Lamers et al., 2020). Here, CRP is linked to metabolic syndrome.